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In this retrospective study, we used whole-genome 
sequencing (WGS) to delineate transmission dynamics, 
characterize drug-resistance markers, and identify risk 
factors of transmission among Papua New Guinea residents 
of the Torres Strait Protected Zone (TSPZ) who had 
tuberculosis diagnoses during 2010–2015. Of 117 isolates 
collected, we could acquire WGS data for 100; 79 were 
Beijing sublineage 2.2.1.1, which was associated with active 
transmission (odds ratio 6.190, 95% CI 2.221–18.077). 
Strains were distributed widely throughout the TSPZ. 
Clustering occurred more often within than between villages 
(p = 0.0013). Including 4 multidrug-resistant tuberculosis 
isolates from Australia citizens epidemiologically linked to 
the TSPZ into the transmission network analysis revealed 
2 probable cross-border transmission events. All multidrug-
resistant isolates (33/104) belonged to Beijing sublineage 
2.2.1.1 and had high-level isoniazid and ethionamide co-
resistance; 2 isolates were extensively drug resistant. 
Including WGS in regional surveillance could improve 
tuberculosis transmission tracking and control strategies 
within the TSPZ.
Tuberculosis (TB) is the leading infectious cause of death globally (1). To reduce the burden of TB, many 
countries committed to achieving a 90% reduction in TB 
incidence by 2035 as part of the End TB Strategy (2). 
Australia has already achieved preelimination targets 
(<10 cases/1 million population) in the nonindigenous, 
Australia-born population (3). However, achieving TB 
elimination in Australia remains a daunting challenge, 
given high population mobility, increased importation of 
TB cases from high-incidence settings, and cross-border 
spread from neighboring countries, such as Papua New 
Guinea (4). In 2013, ≈90% of the TB cases reported in 
Australia were in persons born overseas (3). The state 
of Queensland has one of the lowest TB notification 
rates in Australia (4.0 cases/100,000 population) (5); the 
Western Province of neighboring country Papua New 
Guinea has a significantly higher incidence, estimated 
at 2,901 cases/100,000 population at the provincial 
capital, Daru (6,7).
Daru General Hospital (Port Moresby, Papua New 
Guinea) is the main health center that offers TB health 
services to residents of Western Province, including 
those in the surrounding areas, such as the Torres Strait 
Protected Zone (TSPZ). The TSPZ is an area where free 
bidirectional cross-border movement (without passports 
or visas) is permitted for purposes of traditional customs 
and economic activities (Figure 1); the zone was created 
with the signing of the 1978 Torres Strait Treaty by Papua 
New Guinea and Australia. This area contains a number 
of Papua New Guinea villages and 14 Australia island 
communities (estimated population 1,526) that are part of 
Queensland (9). Cross-border movement of populations 
within the TSPZ provides a potential route of entry of 
Mycobacterium tuberculosis into northern Queensland and 
its spread elsewhere in Australia.
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SYNOPSIS
 Drug-Resistant TB and Torres Strait Protected Zone
In 2012, an Australia resident of the TSPZ was reported 
to have pulmonary TB resistant to streptomycin only. After 
initial improvement with standard therapy, the patient 
deteriorated clinically. Rifampin resistance was detected 
by Xpert MTB/RIF assay (Cepheid, http://www.cepheid.
com), and multidrug-resistant (MDR) TB was confirmed 
after positive culture and drug susceptibility testing. The 
mycobacterial interspersed repetitive unit 24 (MIRU-24) 
profile of the new isolate differed from the initial isolate 
and was characteristic of TB strains in Western Province, 
indicating a possible reinfection with an MDR TB isolate 
(10). This incident was the first notified case of MDR TB 
in a citizen of Australia in the Torres Strait Islands. During 
outbreak epidemiologic investigations, 3 additional MDR 
TB diagnoses were made in citizens of Australia who 
were current or previous residents of the TSPZ. These 4 
cases were epidemiologically linked through a network of 
close contacts. At the time of diagnosis, 2 of the patients 
were living in different Queensland cities distant from 
the TSPZ.
We sought to use whole-genome sequencing (WGS) to 
determine the genomic relationship between these isolates 
and the MDR TB isolates from Papua New Guinea as proof 
of principle for transmission of MDR TB through the TSPZ. 
The discriminatory power of WGS enables the delineation of 
TB transmission with a higher resolution than conventional 
genotyping (11,12). The aim of this study was to use WGS 
and epidemiologic data to determine strain diversity within 
the TSPZ, characterize geno-resistance markers, and identify 
potential risk factors for transmission.
Methods
Strain Selection
All patients receiving TB diagnoses in Queensland 
(including Papua New Guinea citizens receiving TB 
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Figure 1. Communities within and boundaries of Torres Strait Protected Zone. Green arrow indicates Saibai Island, Australia; red arrow 
Mabaduan village, Papua New Guinea; and blue arrow Daru Island, Western province provincial Capital, Papua New Guinea. Inset depicts 
location of Torres Strait Protected Zone between Australia and Papua New Guinea. Operational details on how the 1978 Torres Strait 
Treaty functions can be accessed online (https://dfat.gov.au/geo/torres-strait/Documents/torres-strait-guidelines.pdf). Map obtained with 
permission from Butler JRA, Tawake A, Skewes T, McGrath V. Integrating traditional ecological knowledge and fisheries management in the 
Torres Strait, Australia: the catalytic role of turtles and dugong as cultural keystone species. Ecology and Society. 2012;17:34 (8).
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diagnoses in Queensland clinics in the TSPZ) must be 
reported to the Queensland Department of Health in 
Brisbane. In this study, we included isolates from Papua 
New Guinea citizens residing in the TSPZ who received TB 
diagnoses in the TSPZ during January 1, 2010–December 
31, 2015, which we refer to as cross-border TB isolates. 
We extracted demographic and clinical data from the 
Queensland Notifiable Conditions System on April 6, 2016. 
We included 1 patient given a TB diagnosis previously in 
Papua New Guinea who subsequently sought treatment in 
the TSPZ for extensively drug-resistant (XDR) TB; we also 
included the 4 previously mentioned MDR TB cases in 
residents of Australia because these infections were linked 
to the TSPZ. During the study period, a small number of 
drug-susceptible TB cases (n = 14) were reported among 
Australia citizens residing in the TSPZ, but we did not 
include these cases in this study.
Drug Susceptibility Testing and Genotyping
We performed M. tuberculosis culture, species identification, 
genotyping, and drug susceptibility testing at Queensland 
Mycobacterium Reference Laboratory (Pathology 
Queensland, Brisbane). MIRU-24 or MIRU-15 results 
obtained as previously described (13) were available for most 
isolates. We determined phenotypic susceptibility to first- and 
second-line drugs as previously described (7). On a case-
by-case basis, we used SENSITITRE Microbroth Dilution 
Method (Trek Diagnostic Systems, https://www.thermofisher.
com) to resolve differences between resistance mutations 
detected and phenotypic drug susceptibility test results.
WGS Analysis
We retrieved M. tuberculosis isolates from –80°C storage, 
cultured them on Lowenstein–Jensen medium, and extracted 
isolate DNA using an organic enzymatic method (7). We 
performed WGS at the Australia Genome Research Facil-
ity (Brisbane) using Illumina HiSeq 2000 (https://www.
illumina.com) for paired-end reads, checked the quality of 
reads using FastQC version 0.11.2 (http://www.bioinfor-
matics.babraham.ac.uk/projects/fastqc), and trimmed using 
trimmomatic version 0.27 (14). We mapped reads to refer-
ence genome M. tuberculosis H37Rv (GenBank accession 
no. NC_000962.3) using BWA-MEM (https://arxiv.org/
abs/1303.3997) and used GATK UnifiedGenotyper (15) to 
call single-nucleotide polymorphisms (SNPs) and small in-
sertion/deletions (indels). We selected the SNPs and small 
indels with >10 times read depth, 80% allele frequency, and 
>10-bp difference between neighboring SNPs and indels. 
Using SnpEff version 4.1 (16), we annotated high-quality 
SNPs and indels. We included for analysis mutations in all 
known genes (including regulatory genes) that conferred 
resistance to TB drugs (Appendix Table 1, https://wwwnc.
cdc.gov/EID/article/25/3/18-1003-App1.pdf) and excluded 
mutations in repetitive regions, such as the PE and PPE 
gene family regions. We submitted raw reads in the form of 
FASTQ files to the Sequence Read Archive (project file no. 
PRJNA401368). Scripts of the raw sequence data are avail-
able (https://github.com/arnoldbaino/Daru_scripts).
Phylogenetics and Bayesian Coalescent Analysis
We used data sets from 2 previous independent WGS 
studies, PRJEB7281 and PRJEB2358 (17), as TB 
global representatives in phylogenetic analysis. Using 
concatenated SNP alignment, we constructed a maximum-
likelihood phylogenetic tree with RAxML version 7.4.2 
(18). We used a general time-reversible model, with 
rate heterogeneity accommodated by using discrete rate 
categories (i.e., GTRCAT algorithm), with 1,000 bootstraps 
and visualized using FigTree version 1.4.2 (http://tree.bio.
ed.ac.uk/software/figtree). We performed molecular dating 
of the Beijing lineage isolates using BEAST version 1.8.2 
(19), as previously described (7).
Transmission Assessment
Using ape library in R statistical package (http://cran.r-
project.org), we calculated pairwise SNP differences 
(excluding SNPs in known drug-resistance genes) 
between isolates. We assessed SNP differences by 
lineage and compared these differences between different 
localities to set a threshold as a measure of putative 
transmission. We constructed genomic clusters using a 
median-joining network (Network version 5, http://www.
fluxus-engineering.com/sharenet.htm). We structured 
links within genomic clusters assuming the existence of 
linear transmission among isolates from the same locality 
and putative transmission among isolates from different 
localities (if the SNP difference was within the limit of 
the threshold).
Statistical Analysis and Ethics
We compared patient characteristics using Fisher 
exact test. We performed univariate and multivariable 
logistic regression analyses to evaluate associations 
between patient characteristics and genomic clusters 
as outcome variables to infer transmission. We used 
R statistical package for all statistical analyses. This 
study was approved by the institutional review board of 
the University of Queensland (Brisbane, Queensland, 
Australia; approval no. HREC2015000572) and, as 
required by the Public Health Act of 2005, by Queensland 
Health (approval no. RD006697).
Results
In total, 134 Papua New Guinea citizens were reported 
to have TB in the TSPZ during the study period (Figure 
2), and 117 (87.3%) had culture-confirmed disease. We 
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acquired and successfully sequenced 100 (85.5%) of 
117 isolates from these citizens plus 4 isolates from the 
Australia citizens who resided or previously resided in 
the TSPZ. Isolates were sequenced with a mean coverage 
depth of 74 times (range 42–110 times) and mean coverage 
breadth of 98.5% (range 96.3%–99.8%). MIRU profiles 
were available for 98 of 104 patients (Appendix Table 2). 
Sequence comparisons revealed a median SNP difference 
of 31 (interquartile range [IQR] 24–38) for isolates with 
the same MIRU profile and 1,101 (IQR 1,066–1,119) for 
isolates with different MIRU profiles (Appendix Figure 
1). SNP differences between all possible pairs within the 
data set were bimodal; 2 large peaks represent 2 different 
lineages. The possibility of cross-contamination among 
isolates with no SNP differences was negligible because 
specimens were processed and their DNA sequenced on 
different days. Of the 104 isolates sequenced, phylogenetic 
analysis revealed that 83, including the 4 MDR TB isolates 
from Australia citizens, were part of the modern Beijing 
sublineage 2.2.1.1 and 21 the Euro-American lineage, 
which consisted of 6 different sublineages (Appendix 
Table 3, Figure 2). Although the isolates were widely 
distributed throughout the TSPZ, 50% originated from a 
single Papua New Guinea village, Mabadauan (Appendix 
Figure 3).
Evolutionary analysis of the Beijing sublineage 2.2.1.1 
isolates revealed that 59% (49/83) were related to clades 
previously identified in nearby Daru Island (Appendix 
Figure 4) (7) and 41% were a part of unique clades. The 
isolates from the Australia residents were clade C, which 
we inferred to have emerged in the 1980s.
To determine links between isolates from the same 
and different localities, especially isolates from villages 
with high numbers of isolates from different lineages, we 
deduced a threshold of 8 SNPs to distinguish transmission 
links (Appendix Figure 5). We found 17 genomic clusters 
(14 Beijing lineage, 3 Euro-American lineage) constituting 
74 isolates (65 Beijing lineage, 9 Euro-American lineage) 
among PNG citizens (Figure 3). In total, 89% (34/38) of 
isolates from Mabadauan (identified as Beijing lineage) 
and 100% (4/4) of isolates from Sigabadaru (characterized 
as Euro-American lineage) clustered. More cases (36/41) 
formed genomic clusters in 2011 than in any other year, 
indicative of enhanced transmission leading up to this time 
point (Appendix Figure 6). The number of isolates from 
the same locality that formed genomic clusters (41 Beijing, 
5 Euro-American) was significantly higher than the num-
ber that formed among isolates from different localities 
(24 Beijing, 4 Euro-American; p = 0.0013). The median 
SNP difference was 2 (IQR 1–3) among genomic clusters 
from the same locality and 4 (IQR 2–6) among genomic 
clusters from different localities. Of the 4 Australia cases, 
3 formed 1 MDR TB cross-border genomic cluster hav-
ing 1 SNP difference and a 15-month difference in sample 
collection dates. The fourth isolate was linked to another 
MDR TB cross-border cluster with no SNP differences and 
a 5-month difference in sample collection dates, suggesting 
2 independent episodes of cross-border transmission into 
Australia citizens.
Most cross-border TB isolates in Papua New Guinea 
residents (74%, 74/100) were found in young persons (<35 
years of age) (Table 1), and male and female sexes were 
equally represented. Only 1 (1.4%) of 74 patients tested had 
HIV co-infection. No major differences in characteristics 
were detectable between patients infected with the Beijing 
and Euro-American lineage, except for drug resistance, 
which was strongly associated with the Beijing lineage 
(p<0.001).
Univariate analysis revealed that the Beijing lineage 
(odds ratio [OR] 6.190, 95% CI 2.221–18.077; p<0.0005) 
and resistance to first- and second-line TB drugs (OR 
4.677, 95% CI 1.452–20.943; p = 0.019) were strongly 
associated with transmission (Table 2). In multivariate 
logistic analysis, we adjusted for these 2 characteristics, 
and this analysis showed the Beijing lineage was 
associated with transmission (adjusted OR 4.484, 95% CI 
1.526–13.891). The HIV-infected patient was not part of 
a cluster.
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Figure 2. Flow diagram of included Mycobacterium tuberculosis 
isolates from Papua New Guinea citizens residing in Torres 
Strait Protected Zone, 2010–2015. *Isolates unable to grow or 
were contaminated. †Included were 4 additional isolates among 
Queensland residents that were a part of an epidemiologic cluster 
linked to the Torres Strait Protected Zone. TB, tuberculosis; WGS, 
whole-genome sequencing.
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Phenotypic drug susceptibility testing of all isolates 
showed that 53 (51.0%) were susceptible to all oral first-line 
drugs tested (Appendix Table 4); 1 showed streptomycin 
monoresistance. Drug-resistance patterns observed included 
13.5% (14/104) with isoniazid and streptomycin co-resis-
tance, 31.7% (33/104) with MDR (1 pre-XDR with fluoro-
quinolone resistance), and 1.9% (2/104) with XDR. In 2010 
and 2011, eleven TB cases were MDR or XDR (Appendix 
Figure 6). All MDR and XDR isolates, including the isolates 
from the 4 Australia citizens, belonged to clades C and D of 
Beijing sublineage 2.2.1.1.
Phenotypic and genotypic resistance profiles 
correlated, except for ethambutol (Figure 4). Of the 
35 MDR and XDR isolates, which were also tested for 
second-line drug susceptibility, all carried the fabG1-
inhA mutation (C15T), and 28 (80%) had high-level 
(0.4 µg/mL) isoniazid resistance. In total, 27 of these 28 
had both ndh (ΔG304) and inhA (p.Ile21Val) mutations, 
and 1 had a katG (p.Trp191Arg) mutation. All the 
rifampin-resistant isolates had the same rpoB mutation 
(p.Ser450Leu), and 29 (82.9%) of 35 had compensatory 
mutations in the rpoC gene (27 p.Val483Gly and 
2 p.Trp484Gly). Of note, nearly all isolates with 
compensatory rpoC mutations (28/29) and isolates 
with the fabG1-inhA mutation (48/49) were part of a 
genomic cluster. Of the 2 isolates with the p.Asp94Ala 
gyrA mutation conferring fluoroquinolone resistance, 1 
was XDR; this isolate had pan–second-line injectable 
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Figure 3. Genomic clusters of highly drug-resistant tuberculosis cases among Papua New Guinea and Australia citizens residing or 
previously residing in the Torres Strait Protected Zone, 2010–2015, by lineage. The top shows the Beijing lineage, and the box at bottom 
shows the Euro-American lineage. Each circle represents >1 isolate. Larger circles represent >2 isolates with identical sequences; the 
number of specimens with identical sequences are indicated in parentheses. Details indicated with each circle are locality (initials; QLD 
residents shaded in pink), drug susceptibility (blue shading with blue outline), and drug resistance (multidrug resistance is red shading 
with blue outline, extreme drug resistance is red shading with green outline). Solid lines illustrate plausible transmission links among 
isolates from the same locality, and broken lines represent plausible transmission links among strains from different localities. Small 
nodes between lines represent unidentified ancestral isolates. Number on lines represents single-nucleotide polymorphism differences 
between isolates. BU, Buji; D, Daru; DI, Dimiri; KAD, Kadawa; KAT, Katatai; KIW, Kiwia; KUN, Kunini; KUR, Kurunti; M, Mabadauan; 
OM, Old Mawata; QLD, Queensland; S, Sigabadaru; T, Ture Ture; UN, unknown.
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resistance associated with an rrs (A1401G) mutation. 
The second XDR isolate (from a patient previously 
treated in Papua New Guinea) had a p.Asp89Asn gyrA 
mutation and phenotypic kanamycin resistance without a 
detected mutation conferring aminoglycoside resistance. 
Mutations in genes potentially conferring resistance to 
newly available agents were not identified.
Discussion
We characterized M. tuberculosis strain diversity, 
transmission dynamics, and drug-resistance profiles 
among cross-border isolates from TB patients residing in 
the TSPZ. This region is known for its sparse population, 
unique geography, and ethnic and social diversity, all 
of which can make disease surveillance difficult. The 
identification of drug-resistant isolates in every studied 
year and evidence of cross-border links underscore 
the risk for cross-border importation of drug-resistant 
TB with the potential to spread. Studies conducted 
in other parts of Australia suggest limited local TB 
transmission, despite a high proportion of imported 
TB cases (20,21), but those findings mainly reflected 
occurrences in urban areas. Residents of and visitors to 
the TSPZ might be vulnerable to community outbreaks; 
cultural and family relationships were associated with 
TB transmission in studies of community outbreaks 
within Australia among indigenous populations (22). 
We show that most transmission in the TSPZ occurred 
during local community outbreaks, as demonstrated by 
the high genomic clustering among patients from the 
same locality. With the economic growth anticipated 
in this region (23), interactions between Australia and 
Papua New Guinea populations could increase and affect 
disease notification trends.
The Beijing sublineage 2.2.1.1 dominated among 
isolates, and the Euro-American sublineage isolates were 
diverse. In a previous report, we attributed isolates from the 
same Beijing sublineage responsible for a large MDR TB 
outbreak on Daru Island, which is ≈50 km east of the outer 
islands of the TSPZ (7). The MDR TB outbreak on Daru 
Island was unprecedented in scale (24), but no published 
information described the extent of this outbreak beyond 
the shores of Daru Island.
In our study, most cases were identified to have 
come from Mabadauan, indicating that this setting 
could have a higher migratory rate than other TSPZ 
villages. The high number of drug-resistant TB cases 
from Mabadauan suggests this setting could be another 
hotspot for MDR TB transmission. Control of MDR TB 
transmission with effective clinical and public health–
related interventions in this remote setting is urgently 
needed. Only 59% of Beijing lineage isolates from 
the TSPZ were part of clades previously identified on 
Daru Island (7), illustrating a greater genomic diversity 
for this lineage. This finding might be an indication of 
ongoing microevolution, which could further influence 
transmissibility, acquisition of drug resistance, or 
severity of disease (25).
Our study identified 2 plausible independent 
episodes of drug-resistant TB transmission to Australia 
residents in the TSPZ, a finding that would not have been 
identified by conventional genotyping techniques. Others 
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Table 1. Characteristics of Papua New Guinea residents infected 
with cross-border TB isolates, Torres Strait Protected Zone, 









Age, y  0.739 
 <15 19 (19.0) 15 4 
 15–24 31 (31.0) 26 5 
 25–34 24 (24.0) 19 5 
 35–49 18 (18.0) 13 5 
 >50 8 (8.0) 6 2 
Year  0.324 
 2010 29 (29.0) 22 7 
 2011 42 (42.0) 33 9 
 2012 13 (13.0) 12 1 
 2013 2 (2.0) 1 1 
 2014 8 (8.0) 5 3 
 2015 6 (6.0) 6 0 
Sex  0.876 
 F 45 (45.0) 35 10 
 M 55 (55.0) 44 11 
Sputum smear  0.599 
 Negative 46 (46.0) 34 12 
 Positive 54 (54.0) 45 9 
HIV status  0.234 
 Unknown 26 (26.0) 20 6 
 Negative 73 (73.0) 59 14 
 Positive 1 (1.0) 0 1 
Previous TB episode  0.653 
 No 87 (87.0) 68 19 
 Yes 13 (13.0) 11 2 
Diagnostic delay, d  0.484 
 0–30 53 (53.0) 44 9 
 31–60 18 (18.0) 14 4 
 >61 29 (29.0) 21 8 
MDR or XDR  <0.001 
 No 69 (69.0) 48 21 
 Yes 31 (31.0) 31 0 
Type of TB  0.741 
 Pulmonary 53 (53.0) 43 10 
 Extrapulmonary 7 (7.0) 5 2 
 Both 40 (40.0) 31 9 
Started TB treatment  0.472 
 No 22 (22.0) 15 7 
 Yes 78 (78.0) 64 14 
TB treatment outcome  0.216 
 Transferred or lost to 
follow-up 
66 (66.0) 52 14 
 Cure or complete 
treatment 
22 (22.0) 15 7 
 Defaulted 3 (3.0) 3 0 
 Died 9 (9.0) 9 0 
*MDR, multidrug resistant; TB, tuberculosis; XDR, extensively drug 
resistant. 
†p value calculated by using Fisher exact test. 
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have shown the superiority of WGS over conventional 
genotyping tools for resolving transmission (11,26). 
Two of the Australia patients with MDR TB were 
residing in major urban centers in northern Queensland 
at the time of diagnosis; 1 was living in a residential 
congregate setting, demonstrating the potential for 
diffuse community spread. WGS confirmed that the 
initial isolate noted in the index Australia patient was a 
lineage 4 isolate with only streptomycin resistance (gidB, 
Leu79Ser) (data not shown). This isolate was unrelated 
to the other Euro-American isolates identified and 
different from the subsequent MDR TB Beijing isolate 
identified, consistent with exogenous reinfection or 
endogenous reactivation rather than persistent infection 
with acquired resistance (27).
In another study conducted in Europe, WGS was used 
to investigate MDR TB outbreaks among immigrants and 
traced transmission routes to strains circulating in north-
ern Somalia or Djibouti (28). Although no evidence of 
transmission to citizens of Europe was noted in that study, 
our investigation proves the principle of MDR TB cross-
border transmission. Our findings highlight the challenge 
faced by Australia and Papua New Guinea TB control 
programs to prevent TB transmission through the TSPZ. 
Over the study period, the number of TB cases among 
citizens of Australia in the TSPZ was low (18 cases). 
Most TB notifications on the Australia island communi-
ties of the TSPZ were of diagnoses among Papua New 
Guinea citizens treated in outreach clinics located on the 
outer Torres Strait Islands close to the Papua New Guinea 
border. These clinics were closed in 2012, and all Papua 
New Guinea patients were handed over to the Western 
Province TB program for treatment, and enhanced TB 
services were coordinated from Daru Island. This closure 
and change in services accounts for the sharp fall in noti-
fications in 2012 (Appendix Figure 6).
We observed transmission of a locally evolved Bei-
jing sublineage strain that was associated with resistance to 
first- and second-line TB drugs. Beijing strains are known 
to be associated with increased transmissibility (29–31), 
drug resistance, treatment failure, and rapid progression to 
active disease (32,33). 
Although the World Health Organization estimates 
a high TB incidence among persons living with HIV in 
Papua New Guinea (44 cases/100,000 population) (1), HIV 
incidence in our study was low and did not account for 
the highly successful transmission of Beijing sublineage 
2.2.1.1 in this region. In another study in Gulf Province, 
Papua New Guinea, only 2 HIV-infected persons were 
identified among 105 TB patients (34).
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Table 2. Characteristics associated with Mycobacterium tuberculosis isolate clustering among Papua New Guinea residents, Torres 
Strait Protected Zone, 2010–2015* 
Characteristic No. clustered/total no. OR (95% CI) p value aOR (95% CI)† p value 
Beijing lineage 74/100 
    




 Yes 65/79 6.190 (2.221–18.077) 0.0005 4.484 (1.526–13.891) 0.007 
Age, y 
     




 15–24 25/31 1.488 (0.369–5.841) 0.565 1.298 (0.291–5.614) 0.725 
 25–34 19/24 1.357 (0.320–5.783) 0.673 1.242 (0.260–5.981) 0.782 
 35–49 12/18 0.714 (0.166–2.955) 0.641 0.722 (0.148–3.415) 0.679 
 >50 4/8 0.357 (0.059–2.016) 0.241 0.262 (0.035–1.785) 0.173 
Sex 
     




 M 40/55 0.862 (0.343–2.118) 0.748 0.856 (0.311–2.284) 0.757 
Sputum smear 
     




 Positive 42/54 1.531 (0.624–3.808) 0.352 1.147 (0.423–3.095) 0.784 
Case type 
     




 Recurrent 11/13 2.095 (0.513–14.183) 0.358 1.447 (0.270–11.282) 0.684 
Diagnostic delay, d 
     




 31–59 13/18 0.845 (0.260–3.033) 0.784 1.042 (0.290–4.154) 0.95 
 >60 21/29 0.853 (0.308–2.455) 0.761 1.157 (0.380–3.743) 0.799 
MDR or XDR 
     




 Yes 28/31 4.677 (1.452–20.943) 0.019 2.774 (0.779–13.123) 0.143 
Treatment outcome 
     




 Transferred, lost to follow-up 50/66 2.163 (0.767–6.006) 0.138 1.794 (0.584–5.407) 0.298 
 Defaulted 2/3 NA NA NA NA 
 Died 9/9 NA NA NA NA 
*aOR, adjusted OR; MDR, multidrug resistant; NA, not applicable (large value); OR, odds ratio; XDR, extensively drug resistant. 
†Adjusted for Beijing lineage and drug resistance (MDR or XDR). 
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The high proportion (74%) of TB cases among young 
adults (<35 years of age) in our study suggests ongoing TB 
transmission and is consistent with the finding of another 
study that identified 76.6% of pediatric TB notifications 
in Queensland were from Papua New Guinea residents in 
the TSPZ (35). Further assessment is needed of other risk 
factors, such as medical conditions (e.g., diabetes mellitus, 
high blood pressure) and socioeconomic status, that could 
affect TB transmission.
Excluding ethambutol, we observed a near-perfect cor-
relation between resistance mutations and phenotypic in vi-
tro resistance. One XDR TB isolate had resistance to kana-
mycin (mycobacterial growth indicator tube system critical 
concentration 2.5 µg/mL and a microbroth dilution MIC of 
10 µg/mL), but no known resistance-conferring mutations 
were documented. Isolates with low-level kanamycin re-
sistance are generally thought to display resistance to only 
kanamycin among the aminoglycoside drugs (36), but this 
isolate had a high level of kanamycin resistance. A previous 
study determined that only 80% of phenotypic kanamycin 
resistance could be accounted for by known mutations, in-
dicating unexplained mechanisms of kanamycin resistance 
(37). Although the fabG1-inhA mutation is typically asso-
ciated with low-level isoniazid resistance, we usually ob-
served high-level isoniazid resistance with this mutation, 
possibly because of the accompanying inhA (p.Ile21Val) 
mutation (38). The fabG1-inhA (C15T) mutation does not 
seem to compromise successful spread and has previously 
been documented in clustered M. tuberculosis isolates in 
South Africa (39). One isolate had a fabG1-inhA (C15T) 
mutation with a rare katG mutation (p.Trp191Arg), which 
could affect the conformation of the catalase peroxidase 
protein, considering this mutation is located outside the ac-
tive binding site of isoniazid (40).
Unexpectedly, we observed most rifampin-resistant 
isolates had mutations in rpoC. The fitness cost associated 
with some drug-resistant mutations can be ameliorated by 
compensatory mutations (41). Most isolates (96.5%) with 
rpoC compensatory mutations demonstrated genomic clus-
tering, signifying their probable role in MDR or XDR TB 
transmission. In an assessment of MDR TB isolates in Ar-
gentina, no evidence was found to support the role of rpoC 
mutations in fitness restoration and increased transmis-
sion (42). Higher proportions of compensatory mutations 
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Figure 4. Correlation of 
phenotypic and genotypic drug 
resistance among modern 
Beijing isolates from Papua 
New Guinea and Australia 
citizens residing or previously 
residing in the Torres Strait 
Protected Zone, 2010–2015. No 
resistance mutation detected 
in 1 kanamycin-resistant strain, 
despite targeted sequencing of 
rrs and eis genes. *Pairs of co-
occurring mutations observed 
within the same isolates 
were embA-embB (C12T) 
with embB (p.Asp354Ala) 
and embB (p.Gly406Val) with 
embB (p.Met306Ile). AMGs, 
aminoglycosides; EMB, 
ethambutol; ETA, ethionamide; 
INH, isoniazid; PZA, 
pyrazinamide; RIF, rifampin; 
STR, streptomycin.
SYNOPSIS
414 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 3, March 2019
in MDR TB outbreaks were reported in Shanghai, China 
(66%) (32), and Samara, Russia (87%) (11). More studies 
are needed to assess the role of compensatory mutations in 
MDR and XDR strain transmission.
This study had a few limitations. The retrospective 
study design involved the selection of only 1 isolate per pa-
tient, and some of the stored isolates were unable to be stud-
ied because of failure to recover from culture. Close social 
contact between patients with genomically linked isolates 
could not be confirmed. In other studies, a refined break-
down of transmission patterns was shown with a similar 
approach that included data on social contacts (28,32,43). 
Although the current scope of the study comprised mostly 
Papua New Guinea residents, additional information is 
needed regarding the evolution and transmission dynamics 
among all residents in the TSPZ, including drug-suscepti-
ble isolates in Australia citizens residing in the TSPZ, to 
assess the implications of transmission to populations on 
the Australia mainland.
The combination of genomic and epidemiologic 
data in this study highlighted the wide distribution of 
a Beijing sublineage strain associated with MDR and 
XDR TB in the TSPZ that threatens regional TB control 
through cross-border transmission. Further investigation 
of the environmental, sociocultural, and clinical factors 
that facilitate TB transmission in this region is warranted. 
Supplementation of regional TB surveillance programs 
with WGS technology could improve control strategies.
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